Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Efficacy and tolerability of Lacosamide for focal epileptic patients: Study from epilepsy clinic in Makkah.

< BACK TO ARCHIVE


2020 Aug 18


CNS Neurol Disord Drug Targets


http://www.ncbi.nlm.nih.gov/pubmed/32814542?dopt=Abstract

Efficacy and tolerability of Lacosamide for focal epileptic patients: Study from epilepsy clinic in Makkah.

Authors

Efficacy and tolerability of Lacosamide for focal epileptic patients: Study from epilepsy clinic in Makkah.
Alkhotani A, Abualula H, Almatrafi Y, Ghoniem S, Alkhotani A
CNS Neurol Disord Drug Targets. 2020 Aug 18.
PMID: 32814542.

Abstract

Lacosamide characterized by a novel dual mode of action in its components, in which it has a func-tionalized amino acid that selectively pro, motes inactivation of voltage-gated sodium channels slowly among patients.
Read This Paper